Shimadzu Corporation and Phytronix Technologies sign an agreement to offer the first Triple Ion Source (LDTD-MS/MS, ESI-MS/MS and APCI-MS/MS).

Kyoto, Japan and Québec, Canada – June 5, 2017. Shimadzu, one of the world’s fastest growing mass spectrometry companies, and Phytronix, world leader in high throughput analysis in mass spectrometry, announce today that they have signed an agreement to offer the industry’s first Triple Ion Source. Ideal for both screening and confirmation work, this new... Read more

QIAGEN expands biomarker content portfolio to support greater use of molecular diagnostics for immuno-oncology therapies

Option to add new biomarkers for microsatellite instability (MSI) and mismatch repair (MMR) to QIAGEN’ s NGS panels Hilden, Germany, and Germantown, Maryland, June 3, 2017 – QIAGEN (NASDAQ: QGEN; Frankfurt Prime Standard: QIA) today announced it has received a worldwide license from The Johns Hopkins University for biomarkers that have been shown to play... Read more

NuGEN Technologies Inc. Announces Issuance of US Patent for Its Single Primer Target Enrichment Technology (SPET) for Next Generation Sequencing Applications

San Carlos, California , May 30, 2017 NuGEN Technologies today announced that the United States Patent and Trademark Office has issued US Patent No. US 9,650,628 describing the Single Primer Target Enrichment Technology (SPET) which enables targeted nucleic acid analysis by next generation sequencing (NGS). NuGEN offers commercial solutions using SPET to create target and strand-specific libraries... Read more

New data at ATS add to the body of evidence for Roche’s Esbriet (pirfenidone) in idiopathic pulmonary fibrosis (IPF)

Basel, 24 May 2017 New data at ATS add to the body of evidence for Roche’s Esbriet (pirfenidone) in idiopathic pulmonary fibrosis (IPF) In new post hoc analyses of phase III data, Esbriet reduced the risk of death in patients with more advanced lung function impairment and the risk of respiratory-related hospitalisations as a first... Read more

New data at ATS add to the body of evidence for Roche’s Esbriet (pirfenidone) in idiopathic pulmonary fibrosis (IPF)

Basel, 24 May 2017 New data at ATS add to the body of evidence for Roche’s Esbriet (pirfenidone) in idiopathic pulmonary fibrosis (IPF) In new post hoc analyses of phase III data, Esbriet reduced the risk of death in patients with more advanced lung function impairment and the risk of respiratory-related hospitalisations as a first... Read more

Recent Publications Demonstrate Rapid Adoption of SMRT Sequencing for Plant and Animal Transcriptome Analysis

MENLO PARK, Calif., May 22, 2017 (GLOBE NEWSWIRE) — A series of recent peer-reviewed scientific publications highlights the growing use of Single Molecule, Real-Time (SMRT®) Sequencing to annotate plant and animal genomes. These reports from the genomics community show that PacBio sequencing consistently detects more genes, alternative splicing events, and other important elements compared with... Read more

The EU-funded project CARAT offers fellowships for a training course on CAR T cell manufacturing

BERGISCH GLADBACH, January 24, 2017 – The EU project CARAT has taken on the mission to deliver new tools and technologies to enable the wide use of novel personalized cancer treatment options. In 2017, CARAT will grant five scientists with a fellowship that gives them the opportunity to participate in a unique training. This training, which... Read more

METTLER TOLEDO’s New Weighing Platforms Deliver Hazardous-Area Precision

METTLER TOLEDO’s new PBK9 and PFK9 weighing platforms are designed to deliver the highest precision in your industrial processes. Now, these precision platforms are approved for use in hazardous areas. Since their introduction last year, METTLER TOLEDO’s robust PBK9 bench and PFK9 floor weighing platforms have been helping manufacturers around the world manage raw materials,... Read more